INTRODUCTION

Calophyllum brasiliense
Cambess.
(Clusiaceae), popularly known as "guanandi", is a large tree that grows mainly in the Brazilian Atlantic rainforest, and is distributed in South America from Brazil to Mexico. This tree has been used in folk medicine for the treatment of several diseases such as rheumatism, varicose veins, hemorrhoids and chronic ulcers (Corrêa et al., 1978) .
Previous studies showed that C. brasiliense is a rich source of bioactive compounds, including coumarins (Ito et al., 2003; Reyes-Chilpa et al., 2004) , xanthones (Sartori et al., 1999; Ito et al., 2002) , triterpenoids (Reyes-Chilpa et al., 2004) , and biflavanoids (Da Silva et al., 2001 ). The compounds isolated from C. brasiliense showed cytotoxic activity against some tumor cell lines (Kimura et al., 2005; Ito et al., 2006) , mainly the coumarin mammea A/BB (Reyes-Chilpa et al., 2004; Ruiz-Marcial et al., 2007) . Previous studies have also demonstrated that extracts, fractions, and especially the coumarin (-) mammea A/BB isolated from C. brasiliense leaves show significant molluscicidal activity against Biomphalaria glabrata (Gasparotto et al., 2005) and potent in vitro and in vivo leishmanicidal activity against Leishmania amazonensis and Leishmania braziliensis (Brenzan et al., 2007; 2008a; Honda et al., 2010; Tiuman et al., 2012) . Honda et al. (2010) demonstrated that footpad lesions of mice infected with L. amazonensis decreased in size when the mice were treated topically with 10% dichloromethane extract or intraperitoneally with 100 mg/kg and 200 mg/kg of the hexane fraction of C. brasiliense.
This study contributed to the development of a topical phytomedicinal formulation containing compounds isolated from C. brasiliense, to treat cutaneous leishmaniasis (patent BR200904042-A2). Intraperitoneal administration of the extract at doses of 100 and 200 mg/kg also revealed healing lesions. The parasite load in the popliteal lymph nodes was significantly reduced in treated animals, showing that the plant components actually control infection (Honda et al., 2011) . Other studies have also demonstrated the antileishmanial activity of the (-) mammea A/BB derivatives against L. amazonensis . Mammea A/BB isolated from C. brasiliense leaves showed trypanocidal activity against Trypanosoma cruzi (Reyes-Chilpa et al., 2008) . Considering these effects, a method for quantitative analysis of the biologically active compound (-) mammea A/BB in the extract from C. brasiliense by means of high-performance liquid chromatography (HPLC) was validated by Brenzan et al. (2010) .
Taken together, the results of the studies involving biological effects, mainly the antileishmanial activity of this plant, led us to evaluate the potential for chromosomal damage of the extract from C. brasiliense leaves, in erythrocytes from mouse bone marrow
MATERIALS AND METHODS
Plant
Aerial parts of C. brasiliense were collected at the Botanical Institute of São Paulo, Brazil, on 13/09/2012. The plant material was identified by Prof. Dr. Maria Claudia M. Young, and a voucher specimen (SP 363818) was deposited and authenticated at the herbarium of this institute. The leaves were dried at 45°C in a circulating-air oven and triturated in a knife mill (Usi Ram ® ), and the resulting powder was stored in a dry location in the dark.
Plant extraction
The powdered leaves (825.0 g) were extracted by exhaustive maceration in ethanol/water (9:1) at room temperature, until depleted of all compounds. The extract was filtered and concentrated under vacuum at 40°C to obtain an aqueous extract and a dark-green residue. The residue from the extract, stored in glass bottles, was dissolved with dichloromethane, and the solvent was then completely evaporated at room temperature; this extract was termed the crude extract (31.5 g). The aqueous extract was lyophilized (148.0 g). Both were stored at -10°C, in the dark, until use (Brenzan et al., 2007) .
HPLC analyses
The HPLC analyses of the crude extract from C. brasiliense leaves were carried out according to Brenzan et al. (2010) . A Shimadzu LC-10 liquid chromatography equipped with a quaternary pump (LC-10 AD), automatic injection valve (Rheodyne) with a 20 ml loop, degasser (DEU-14), thermostatted column compartment from (CTO-10Avp), and a detector UV/vis (SPD-10A), controlled by the software CLASS LC-10 were used. The sample extracts were prepared in methanol at 3 mg/ml and filtered through a Millex  0.45 µm membrane filter (Millipore, Brazil); then, 20 µl was injected into the HPLC system. A Metasil ODS column, 5 mm, 150 × 4.6 mm maintained at 30°C was used in the chromatographic analysis. The separation was performed in a gradient system, using as mobile 
Animals and treatments
The experimental protocol was approved by the Animal Ethics Committee of Maringá State University (protocol number 037/2011).
The in vivo assay for chromosomal damage was carried out in female albino Swiss mice, approximately 7 to 8 weeks old and with a mean weight of 39.8 g. The mice were obtained from the Animal Facility of the State University of Maringá. The animals were kept in polyethylene cages with controlled temperature (25°C) in a 12/12 h light-dark cycle. Food and water were provided ad libitum. The feed was a standard commercial rodent chow (Nuvilab ® ). The mice were housed in groups of six per cage and randomly divided into four groups, which received via orogastric gavage: (1) 1% DMSO (negative control), (2) 50 mg/kg of Cyclophosphamide (positive control), (3) 100 mg/kg of crude extract from C. brasiliense and (4) 200 mg/kg of crude extract from C. brasiliense. After 24 h, the animals were anesthetized through intraperitoneal injection of ketamine (60 mg/kg) and xylazine (12 mg/kg). The bone marrow was removed from the femur, and the animals were euthanized.
Micronucleus assay
The genotoxic effects of the C. brasiliense extract were evaluated in bone-marrow cells of mice by the micronucleus test, according to Schmid (1975) . Immediately after the animals were anesthetized, the femurs were removed. The bone marrow was removed, emulsified, and transferred to centrifuge tubes containing 2 ml of fetal bovine serum (FBS). The bone-marrow suspension was centrifuged at 1000 rpm for 5 min and the supernatant was discarded. The pellet was resuspended in one drop of FBS, and one drop of this suspension was applied to a slide to prepare the smears. After 24 h of drying at room temperature, the smears were stained (May-Grünwald Giemsa) and the slides were again dried at room temperature.
The smears were examined under an optical microscope (Olympus, Japan) at 1000 × magnification. The criteria for counting micronuclei were based on the diameter, shape and coloration of micronuclei, according to Krishna and Hayashi (2000) . To assess the induction of micronuclei formation (MN), the number of micronucleated polychromatic erythrocytes (MNPCE) in 1000 polychromatic erythrocytes (EPC) per animal and per slide was determined (Schmid, 1975) .
Statistical analysis
The results were expressed as mean ± standard deviation (SD), to compare the frequencies of MNPCE between the treated and control groups. The micronucleus assay data were statistically analyzed by ANOVA followed by Tukey's test. P≤ 0.05 was considered statistically significant.
RESULTS
HPLC analysis of the C. brasiliense extract
In the chromatogram of the extract from C. brasiliense leaves, with a retention time of 26.2 min, the coumarin (-) mammea A/BB was identified as the majority compound (Figure 1 ). This extract showed a concentration of 25.97 ± 0.91 µg of (-) mammea A/BB per mg of crude extract. The content of this compound in the C. brasiliense extract was analyzed according to the methodology proposed by Brenzan et al. (2010) , and the results were in agreement with this previous study.
Micronucleus test
The frequencies of micronucleated polychromatic erythrocytes (% MNPCE ± standard deviation (SD)) of the negative control and the groups that received 100 or 200 mg/kg of crude extract of C. brasiliense were 2.34 ± 1.6, 1.84 ± 1.2, and 3.0 ± 3.0%, respectively. The frequencies of MNPCE for mice treated with 100 or 200 mg/kg of the crude extract were similar to the negative control (Tukey's ANOVA Test, p ≤ 0.05). The frequency of MNPCE for the positive control group (16.83 ± 8.4%) (Figure 2 ) differed significantly (p ≤ 0.05) from the negative control group and from the groups treated with 100 or 200 mg/kg of the crude extract of C. brasiliense ( Table 1) .
DISCUSSION
Coumarins are heterocyclic molecules that have been associated with beneficial effects in reducing the risk of cancer, diabetes, and cardiovascular and brain diseases. These effects are related to the elimination of free radicals, due to their antioxidant activities. Gonçalves et al. (2013) demonstrated that dichloromethane extracts and extracts obtained by supercritical fluid from C. brasiliense leaves showed a significant content of the coumarin (-) -mammea A/BB, with high antioxidant activity.
Micronuclei in interphase cells result from chromosome breakage or delayed chromosomal and DNA damage; in eukaryotic organisms or individual cells, this damage is often evaluated with the comet assay (García et al., 2004) . The high content of (-) mammea A/BB in the dichloromethane extracts obtained from leaves of C. brasiliense may be effective in reducing oxidation of DNA by free radicals.
The crude extract of C. brasiliense leaves, with a concentration of (-) mammea A/BB at 25.97 ± 0.91 µg/mg of extract was used in two doses, that is, 100 and 200 mg/kg, to evaluate the induction of micronuclei in erythrocytes from bone marrow. This is the primary in vivo genotoxicity test recommended by regulatory agencies worldwide, as part of the safety assessment of chemicals chemicals and natural products. This test, when performed correctly, detects both clastogenic and aneugenic effects (Krishna and Hayashi, 2000) .
The micronuclei in young erythrocytes arise mainly from acentric fragments or chromosomes that are unable to migrate following the mitotic spindle during cell division of hematopoietic tissue (Salamone and Heddle, 1983; Ouanes et al., 2003) . The increase in the frequency of MNPCE in animals treated with different compounds is an indication of induced chromosome damage (Krishna and Hayashi, 2000) .
The frequency of MNPCE in groups treated with the crude extract from C. brasiliense was significantly lower than the frequencies observed in the positive control. Cyclophosphamide has been widely used as a positive control in the micronucleus test with rodents (Krishna and Hayashi, 2000) , because of its ability to induce MNPCE. However, the decrease in frequency of MNPCE compared to the controls suggests that the crude extract from C. brasiliense leaves does not act as a genotoxin, and it may also contain compounds that have an antigenotoxic effect.
This study was the first to evaluate the potential for chromosomal damage of the C. brasiliense extract in mouse bone-marrow cells. The results indicate that the compounds present in this extract did not cause a significant increase in the number of cells with micronuclei at doses of 100 and 200 mg/kg. These doses are higher than that received by human patients using creams with antileishmanial activity (Honda et al., 2010 (Honda et al., , 2011 .
Conclusion
The results of this study demonstrated that the extracts from C. brasiliense are safe, at least in terms of the potential for chromosomal damage.
